Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (40) Blankenstein, Thomas Prof. Dr. (39) Clauß, Julian (1) Daniel, Peter Prof. Dr. (1) Fischer, Cornelius Dr. (2) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Kammertöns, Thomas Dr. (5) Kieback, Elisa Dr. (2) Lee, Young-Ae Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (1) Marenholz, Ingo Dr. (1) Na, Il-Kang Dr. (1) Pezzutto, Antonio Prof. Dr. (3) Rehm, Armin Dr. (1) Schlag, Peter M. Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (5) (-) Bunse, Mario Dr. (2) (-) Conrad, Thomas Dr. (1) (-) Kopp, Joachim Dr. (1) (-) Willimsky, Gerald Dr. (13) (-) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) (-) 2007 (2) (-) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) 2015 (2) 2016 (1) 2017 (1) (-) 2018 (5) 2019 (3) 2020 (2) 2021 (1) 2022 (8) 2023 (8) 2024 (1) Cellular Neurosciences (2) Developmental Biology / Signal Transduction (1) Experimental Ultrahigh-Field MR (3) Genetics of Metabolic and Reproductive Disorders (5) (-) Genomics (1) Immune Regulation and Cancer (2) Magnetic Resonance (3) Mobile DNA (1) (-) Molecular Immunology and Gene Therapy (15) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (1) Translational Oncology of Solid Tumors (1) 16 Results: Active Filter: Bunse, Mario Dr.Conrad, Thomas Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.GenomicsMolecular Immunology and Gene Therapy199720022007200820132018 Sort: Result score Newest to oldest Oldest to newest December 01, 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein October 01, 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein November 01, 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel January 01, 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto June 19, 2018 / Cell Rep Transient N-6-methyladenosine transcriptome sequencing reveals a regulatory role of m6A in splicing efficiency A. Louloupi E. Ntini T. Conrad U.A.V. Ørom August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel May 01, 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse Pagination Current page 1 Page 2 Next page Next › Last page Last »
December 01, 2007 / Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
October 01, 2007 / Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
July 07, 2008 / J Exp Med Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness G. Willimsky M. Czeh C. Loddenkemper J. Gellermann K. Schmidt P. Wust H. Stein T. Blankenstein
October 01, 2008 / Int J Cancer SV40 large T antigen-transformed human primary normal and cancerous mammary epithelial cells are phenotypically similar but can be distinguished in 3D culture with selection medium L.P. Li G. Willimsky S. Seitz Y. Xu Y. Li L.E. Schwarz P.M. Schlag T. Blankenstein
November 01, 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
January 01, 1997 / Exp Hematol Successful retroviral mediated transduction of a receptor gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells A. Aicher J. Westermann S. Cayeux G. Willimsky K. Daemen T. Blankenstein W. Uckert B. Doerken A. Pezzutto
June 19, 2018 / Cell Rep Transient N-6-methyladenosine transcriptome sequencing reveals a regulatory role of m6A in splicing efficiency A. Louloupi E. Ntini T. Conrad U.A.V. Ørom
August 30, 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
June 01, 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
May 01, 2018 / Hum Gene Ther Efficient non-viral T cell engineering by Sleeping Beauty minicircles diminishing DNA toxicity and miRNAs silencing the endogenous TCR J. Clauss M. Obenaus C. Miskey Z. Ivics Z. Izsvák W. Uckert M. Bunse